Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerda Egger

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Nature Communications|March 4, 2015
Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesisBeatrice Grabner, Daniel Schramek, Kristina M Mueller, et al.
The EMBO Journal|September 29, 2021
DNA hypomethylation leads to cGAS-induced autoinflammation in the epidermisMirjam A Beck, Heinz Fischer, Lisa M Grabner, et al.
Molecular Systems Biology|April 24, 2020
STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancerMonika Oberhuber, Matteo Pecoraro, Mate Rusz, et al.
Molecular Cancer|November 1, 2024
Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironmentChristina Sternberg, Martin Raigel, Tanja Limberger, et al.
Molecular Cancer|July 7, 2026
Correction: Cell‑autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53‑driven senescence and confers an immune‑active tumor microenvironmentChristina Sternberg, Martin Raigel, Tanja Limberger, et al.
Molecular Cancer|May 29, 2024
JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progressionTorben Redmer, Martin Raigel, Christina Sternberg, et al.
International Journal of Cancer|October 9, 2020
Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancerOsman Aksoy, Jan Pencik, Markus Hartenbach, et al.
Nature Medicine|October 16, 2012
PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomasDaniela Laimer, Helmut Dolznig, Karoline Kollmann, et al.
Nature Communications|July 23, 2015
STAT3 regulated ARF expression suppresses prostate cancer metastasisJan Pencik, Michaela Schlederer, Wolfgang Gruber, et al.
Nature Communications|October 27, 2015
Erratum: STAT3 regulated ARF expression suppresses prostate cancer metastasisJan Pencik, Michaela Schlederer, Wolfgang Gruber, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Nature Communications|March 4, 2015
Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesisBeatrice Grabner, Daniel Schramek, Kristina M Mueller, et al.
The EMBO Journal|September 29, 2021
DNA hypomethylation leads to cGAS-induced autoinflammation in the epidermisMirjam A Beck, Heinz Fischer, Lisa M Grabner, et al.
Molecular Systems Biology|April 24, 2020
STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancerMonika Oberhuber, Matteo Pecoraro, Mate Rusz, et al.
Molecular Cancer|November 1, 2024
Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironmentChristina Sternberg, Martin Raigel, Tanja Limberger, et al.
Molecular Cancer|July 7, 2026
Correction: Cell‑autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53‑driven senescence and confers an immune‑active tumor microenvironmentChristina Sternberg, Martin Raigel, Tanja Limberger, et al.
Molecular Cancer|May 29, 2024
JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progressionTorben Redmer, Martin Raigel, Christina Sternberg, et al.
International Journal of Cancer|October 9, 2020
Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancerOsman Aksoy, Jan Pencik, Markus Hartenbach, et al.
Nature Medicine|October 16, 2012
PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomasDaniela Laimer, Helmut Dolznig, Karoline Kollmann, et al.
Nature Communications|July 23, 2015
STAT3 regulated ARF expression suppresses prostate cancer metastasisJan Pencik, Michaela Schlederer, Wolfgang Gruber, et al.
Nature Communications|October 27, 2015
Erratum: STAT3 regulated ARF expression suppresses prostate cancer metastasisJan Pencik, Michaela Schlederer, Wolfgang Gruber, et al.
Pageof 10